Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Dec 7;13(12):2454.
doi: 10.3390/v13122454.

Prevalence and Distribution of HPV Genotypes in Immunosuppressed Patients in Lorraine Region

Margot Boudes  1   2 , Véronique Venard  2   3 , Thierry Routiot  4 , Marie Buzzi  2 , Floriane Maillot  1   2
Affiliations
Observational Study

Prevalence and Distribution of HPV Genotypes in Immunosuppressed Patients in Lorraine Region

Margot Boudes et al. Viruses. .

Abstract

Background: The primary objective of this work was to assess the prevalence and distribution of HPV genotypes in immunosuppressed patients, and to compare them with the French Monsonego cohort. Secondary objectives were to evaluate whether the risk of HPV infection was correlated with HIV viral load, CD4 cell count in HIV-infected patients and the type, number of immunosuppressive therapies or type of pathology (transplant vs. autoimmune diseases) in patients undergoing long-term immunosuppressive therapy.

Methods: An observational, monocentric and historical study was conducted including all immunosuppressed patients having received an HPV testing, in the Laboratory of Virology, Nancy Regional Teaching Hospital Center, between 2014 and 2020. Immunosuppressed patients were either HIV-infected or received long-term immunosuppressive therapy.

Results: In our cohort, the prevalence of HPV infection (75.6% vs. 16.1% p < 0.05), the proportion of patients with high-risk HPV infection (48.9% vs. 15.1% p < 0.05) and with multiple HPV infection (41.1% vs. 5.7% p < 0.05) were significantly higher than in the Monsonego cohort. HPV 52 (13%), 53 (13%) and 16 (10%) were the most common in the immunosuppressed population, while it was HPV 16, 42 and 51 in the Monsonego cohort.

Conclusions: This study supports that a particular attention must be given to all the immunosuppressed patients for the screening and care of HPV-related diseases because of major modifications of HPV epidemiology compared with the overall population.

Keywords: HIV; HPV genotypes; human papillomavirus; immunosuppressed patients; immunosuppressive therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart.
See this image and copyright information in PMC

References

    1. Le VIH/Sida en France en 2018. [(accessed on 4 August 2021)]. Available online: https://vih.org/dossier/le-vih-sida-en-france-en-2018/
    1. L’activité de Greffe d’organes Repart à la Hausse en 2019—Agence de la bioméDecine. [(accessed on 21 August 2021)]. Available online: https://www.agence-biomedecine.fr/L-activite-de-greffe-d-organes-repart-....
    1. Liste des Maladies Auto-Immunes—CRMR des Maladies Auto-Immunes de Strasbourg (RESO) [(accessed on 21 August 2021)]. Available online: https://maladie-autoimmune.fr/maladies-auto-immunes/
    1. Reusser N.M., Downing C., Guidry J., Tyring S.K. HPV Carcinomas in Immunocompromised Patients. J. Clin. Med. 2015;4:260–281. doi: 10.3390/jcm4020260. - DOI - PMC - PubMed
    1. Berrébi A., Badiou W., Duclusaud A. Frequency, persistence and recurrence of HPV lesions of the uterine cervix in HIV-seropositive women. Gynecol. Obstet. Fertil. 2008;36:521–524. doi: 10.1016/j.gyobfe.2008.02.007. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources